ニコチナミドは,フリードリヒ症のアタキシア:有用か否か?
David R Lynch1, Kenneth H Fischbeck2
1Division of Neurology and Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Lancet (London, England)
|May 6, 2014
まとめ
No abstract available in PubMed .
さらに関連する動画
関連する概念動画
Role of Reduced Coenzymes NADH and FADH₂
11.8K
The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
11.8K
Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K


